Bicycle Therapeutics
BCYC
109 hedge funds and large institutions have $278M invested in Bicycle Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 11 closing their positions.
146% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $947K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
21% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 29
10% more funds holding
Funds holding: 99 → 109 (+10)
4.45% more ownership
Funds ownership: 74.01% → 78.46% (+4.4%)
3% less capital invested
Capital invested by funds: $286M → $278M (-$7.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$4.31M |
| 2 |
BNP Paribas Asset Management
Paris,
France
|
+$4.19M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.63M |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$2.28M |
| 5 |
AC
Armistice Capital
New York
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.37M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3.65M |
| 3 |
Morgan Stanley
New York
|
-$2.64M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.61M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.57M |
BCYC Hedge Fund Activity: Q4 2025 in Review
109 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q4 2025, worth a combined $278M — down 2.8% from $286M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new BCYC positions and 11 closed out — a net gain of 11 holders — while 35 added to existing stakes and 29 trimmed.
The largest buyer was Schroder Investment Management Group, opening a new position worth an estimated $4.31M. The largest seller was Millennium Management, cutting an estimated $5.37M.
- 109 institutional investors held Bicycle Therapeutics (BCYC) as of Q4 2025, up from 99 in Q3 2025.
- Funds reported $278M of Bicycle Therapeutics stock for Q4 2025, down 2.8% quarter-over-quarter.
- 22 funds opened new Bicycle Therapeutics positions in Q4 2025 and 11 closed out, a net change of +11 holders.
- The largest Bicycle Therapeutics buyer in Q4 2025 was Schroder Investment Management Group, an estimated $4.31M added.
- The largest Bicycle Therapeutics seller in Q4 2025 was Millennium Management, an estimated $5.37M sold.
Based on aggregated 13F filings for Q4 2025.